Health IT Roundup—UConn Health data breach impacts 300K patient records; Cedars-Sinai pilots Amazon Alexa in patient rooms

FierceHealthcare | February 27, 2019

The University of Connecticut Health Center is notifying patients of a data breach due to an unauthorized third party illegally accessing employee email accounts. UConn Health learned of the phishing attack on Dec. 24 and determined that some of the accounts contained some personal and medical information, including some patients’ names, dates of birth, addresses and limited medical information, such as billing and appointment information, UConn Health officials said in an announcement posted on its website Friday. The incident had no impact on the organization’s computer networks or electronic medical record systems, officials said. A local news station, WFSB, reported that 326,000 patient records may have been exposed, including 1,500 that included Social Security numbers.

Spotlight

Physicians and patients are now faced with changes in payment models-and doctors can help shape the future of healthcare toward being based on outcomes rather than fighting for reimbursements, individual procedures, or piecemeal parts of the healthcare system, according to U.S. Surgeon General, Vice Admiral Jerome M. Adams, MD, MPH.

Spotlight

Physicians and patients are now faced with changes in payment models-and doctors can help shape the future of healthcare toward being based on outcomes rather than fighting for reimbursements, individual procedures, or piecemeal parts of the healthcare system, according to U.S. Surgeon General, Vice Admiral Jerome M. Adams, MD, MPH.

Related News

HEALTHTECH SECURITY

Providers Now Have Free Access to Latest Diabetes Technology in One Place

Association of Diabetes Care & Education Specialists (ADCES) | October 14, 2022

All healthcare professionals caring for people with diabetes now have access to vital information about the latest diabetes technology in one place through the Association of Diabetes Care & Education Specialists' (ADCES) newly revamped danatech website. Launched in 2018, danatech has been updated and enhanced. ADCES now provides free danatech access to all healthcare professionals, from the nurse who is trying to determine if insurance will cover a prescription for a continuous glucose monitor (CGM) to the provider who wants to compare the various insulin pumps to the radiologist who wants to know whether a patient should remove their device before having an MRI. Site visitors can also access training and education on the devices, including many for continuing education (CE/CME) credit. Many of these offerings are free. "The number of people with diabetes is skyrocketing and there aren't nearly enough specialists to treat them all, healthcare professionals in multiple practice settings are caring for people with diabetes. But many are not familiar with the multitude of new technologies and devices available to those who need them the most. These technologies and devices generate the data that allows for effective care planning and danatech helps healthcare professionals get up to speed so they can collaborate with their patients most effectively to self-manage their diabetes." Leslie Kolb, DrPH, MBA. BSN, RN, chief science, practice and learning officer for ADCES The easy-to-navigate site includes information on apps and digital therapeutics designed to prevent, manage and/or treat diabetes and features CGM insurance lookup tool to determine whether a patient's insurance pays for a CGM prescription. Information for all brands of CGMs, insulin pumps and insulin/medicine delivery systems. Free and fee-based training and education for CE/CME on the various devices. Three certificate programs: Putting Continuous Glucose Monitoring (CGM) Into Practice, Connected Insulin Devices and The Art of Telehealth. "While some of these resources are available elsewhere, it's piecemeal, whereas danatech brings it all together," said Kolb. "For example, if a provider wants to compare insulin pumps to determine which would be best for a patient, they'd have to visit each of the manufacturer's websites individually. Now they don't."

Read More

HEALTH TECHNOLOGY

Redox and Intelligent Medical Objects Partnering to Augment Healthcare Data

Redox Inc. | October 18, 2022

Redox, the company setting the stage for composable healthcare, has partnered with Intelligent Medical Objects, a healthcare data enablement company to standardize clinical data from diverse systems into consistent, structured, clinically validated terminology including comprehensive mapping to major global coding systems. Now healthcare companies can spend more time building improved patient and clinician experiences by eliminating the lengthy and taxing process of combining multiple point solutions. This announcement comes directly after last week's launch of API Actions, a modular way for healthcare companies to build out their ideal workflows. This present partnership between IMO and Redox benefits any healthcare company that receives clinical problem or diagnosis data from multiple organizations. As a result, these are further able to enrich healthcare data using consistent terminology across all data standards, formats, and workflows with a single Redox API. "Redox is dedicated to making sure that healthcare data can empower builders to create new experiences for patients and providers. We want to be clear that composable healthcare is a practice of bringing together the best technologies to produce the best solutions, and we're glad to be doing so with IMO." Redox CEO Luke Bonney "Clinical patient data is a powerful resource in healthcare. IMO partnering with Redox will accelerate the ability for healthcare companies to leverage that data to create better outcomes for doctors and patients," said IMO CEO Ann Barnes. Redox will leverage IMO's technology to standardize healthcare data for its customers. Using IMO Precision Normalize will allow Redox to accelerate data normalization for its hospital and software vendor clients. This lets healthcare technology companies spend more time building powerful solutions by eliminating the lengthy and costly process of cleaning and standardizing messy clinical data. SNOMED® is a registered trademark of International Health Terminology Standards Development Organisation About Redox Payers, providers, digital health companies, and other healthcare entities use Redox to produce differentiated experiences for patients and clinicians. Connecting to more than 30,000 healthcare organizations, Redox provides a composable software experience across the healthcare ecosystem. With our single API, product teams are empowered to build whatever they can imagine. Redox accelerates innovations that make healthcare data more useful than ever before. About IMO Intelligent Medical Objects is a healthcare data enablement company. From clinical documentation at the point of care to complex approaches to population health management, IMO ensures clinical data integrity and quality—making patient information fit-for-purpose across the healthcare ecosystem. For almost three decades, IMO's footprint in EHRs—across more than 4,500 US hospitals—powers our expert ability to capture and preserve clinical intent wherever and however data is used. Our primary clients span individual doctors and physician groups, hospitals and clinics, large integrated delivery networks, inpatient ORs and surgical centers, global electronic health record providers, health information exchanges, clinical data registries, payers, life sciences companies, and healthcare analytics vendors.

Read More

HEALTH TECHNOLOGY

Veranex Expands European MedTech Capabilities With Acquisition of Medidee

Veranex and Medidee Services | September 21, 2022

Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry, announced that it has acquired Medidee, a top MedTech consultancy company headquartered in Lausanne, Switzerland. As a trusted European regulatory and quality service consultancy joining Veranex, Medidee expands and strengthens regulatory affairs, clinical development, and quality assurance services and capabilities for MedTech companies across Europe and the world. This improved ability to navigate the European Union’s Medical Device and In Vitro Diagnostic Device Regulations challenges supports truly full-service MedTech product development and commercialization. “Our acquisition of Medidee significantly expands our European footprint while also materially expanding the scale and scope of the clinical studies we can manage. The combined organization offers offices and expertise across Europe, the U.S., and Asia, augmenting our ability to help MedTech innovators achieve FDA and CE Mark approvals and uninterrupted market access for new as well as proven medical technologies that advance patient care.” Veranex CEO David Dockhorn With Medidee’s 11 locations across Europe, India, and Asia-Pacific, and Veranex’s 13 locations across the U.S., Europe, and China, the company now has unprecedented reach to serve clients with a full spectrum of integrated concept-to-commercialization services — design, engineering, regulatory, quality, preclinical research, clinical development, clinical operations, commercial strategy, and market access services — all under one umbrella. Medidee is one of the Top 3 medical device consultancy service providers in Europe uniquely positioned as a leader in future key areas such as digital health, machine learning, and cybersecurity. The company also brings expertise in clinical research exclusively focused on medical devices and in vitro diagnostics. “Medidee has a proven track record serving regulatory, clinical, and quality needs for companies of all sizes, with consulting expertise and clinical trial support in increasingly diverse therapeutic areas and technology categories across multiple geographies,” shared Medidee co-founders Kim Rochat, Philippe Etter, and Michael Maier. “With these services, coupled with the global infrastructure of Veranex, we expand expertise and resources for the benefit of our clients as well as for all EU innovative manufacturers wishing to access rapidly and efficiently the U.S. market and beyond. We look forward to providing these additional strengths and capabilities,” added the co-founders who take on new roles in the combined organization. About Veranex Veranex is the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry. Offering expert guidance from concept to commercialization and across the development continuum, Veranex enables accelerated speed to market, controlled development costs, development risk mitigation, and accelerated market viability assessment. At every stage, Veranex customers realize efficiencies in cost and time, while its comprehensive solutions unify and streamline the entire development process. Veranex is backed by Summit Partners, Accelmed, and Lauxera Capital Partners. About Medidee Services With sites in Switzerland, Germany, Denmark, Belgium, Spain, USA, and APAC, Medidee is a global services supplier serving companies ranging from academic startups to majors. Medidee was established by three partners, all experts in the field of medical devices. With 50 experts in all fields necessary to ensure compliance with the most stringent requirements, Medidee provides the necessary competencies to ensure and demonstrate compliance with all key medical device regulations. Medidee expends regularly to provide the best resources and competencies and supports more than 350 manufactures all over the world.

Read More